NDA Submission Status -- D-PLEX100 rolling New Drug Application was initiated with the FDA on March 30, 2026, with CMC, nonclinical, and administrative modules submitted, and the clinical module ...
Drilled 9 (9.0 net) wells and brought 10 (10.0 net) wells on production, with F&D capital expenditures totalling $107.4 million in Q1 2026. At March 31, 2026, Birchcliff had invested approximately 31% ...
The Chinese Side Has Scrupulously Honored the Phase One Economic and Trade Agreement III. The US Side Has Failed to Meet Its Obligations Under the Phase One Economic and Trade Agreement As the world's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results